Clinical Trial Update: A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing safety and efficacy of insulin degludec versus insulin glargine, both used with mealtime insulin aspart in adults with type 1 diabetes; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• Insulin aspart (insulin aspart)
• insulin degludec (insulin degludec)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2017-05-15